Tecartus (brexucabtagene autoleucel) for the Treatment of Mantle Cell Lymphoma (MCL)

Image 3-Tecartus
MCL is a rare type of Non-Hodgkin’s cancerous B-cell lymphoma. Credit: Kite, a Gilead Company.